Document Type

Capstone Experience

Graduation Date

12-2025

Degree Name

Master of Public Health

Department

Health Promotion

First Committee Member

Chad Abresch, PhD

Second Committee Member

Ron Shope, PhD

Third Committee Member

Ashley Deschamp, MD

Fourth Committee Member

Kari Neemann, MD

Abstract

Bronchiolitis is the leading cause of hospitalization among infants under six months, yet treatment remains largely supportive due to clinical guidelines that discourage pharmacologic intervention. Recent research suggests that bronchiolitis is not a uniform condition, and a subgroup of infants (those classified within “Profile A”) may benefit from targeted corticosteroid therapy. However, these treatments remain outside current clinical guidelines, and their successful adoption depends on stakeholder acceptability. This Capstone project developed and refined four data collection instruments- two questionnaires and two interview guides- designed to assess how healthcare providers and caregivers perceive the acceptability of corticosteroid treatment for Profile A bronchiolitis using the Theoretical Framework of Acceptability (TFA). Four subject matter experts provided feedback on questionnaire clarity, comprehensiveness, and appropriateness by completing both the provider and caregiver versions. The project chair offered additional feedback on interview guide structure and flow through pilot testing. Findings from the expert review informed substantive revisions to both instruments, including educational scaffolding, structural refinements, and stakeholder-specific construct operationalization. The refined instruments are now ready for implementation in a planned multi-site pilot study pending grant funding. This project contributes to early-stage implementation research on phenotype-guided bronchiolitis treatment by ensuring that acceptability assessment tools are theoretically grounded and feasible for real-world use.

Download

Available for download on Tuesday, June 09, 2026

Share

COinS